These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 2492738)
1. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis. van Wijk LM; Crijns HJ; van Gilst WH; Wesseling H; Lie KI Am Heart J; 1989 Feb; 117(2):365-9. PubMed ID: 2492738 [TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia. Hoff PI; Tronstad A; Oie B; Ohm OJ Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing. Furlanello F; Guarnerio M; Inama G; Vergara G; Del Greco M; Bertoldi A; Dallago M Am J Cardiol; 1992 Aug; 70(5):19A-25A. PubMed ID: 1509994 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia. Hellestrand KJ Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396 [TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of flecainide for supraventricular tachycardia. Neuss H; Schlepper M Am J Cardiol; 1988 Aug; 62(6):56D-61D. PubMed ID: 3136637 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia. Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination]. Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426 [TBL] [Abstract][Full Text] [Related]
9. Clinical experience with a new software-based antitachycardia pacemaker for recurrent supraventricular and ventricular tachycardias. Fromer M; Gloor H; Kus T; Shenasa M Pacing Clin Electrophysiol; 1990 Jul; 13(7):890-9. PubMed ID: 1695746 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Gambhir DS; Bhargava M; Arora R; Khalilullah M Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090 [TBL] [Abstract][Full Text] [Related]
11. Summary of efficacy and safety of flecainide for supraventricular arrhythmias. Anderson JL; Jolivette DM; Fredell PA Am J Cardiol; 1988 Aug; 62(6):62D-66D. PubMed ID: 3136638 [TBL] [Abstract][Full Text] [Related]
12. Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia. Zee-Cheng CS; Kim SS; Ruffy R Am J Cardiol; 1988 Aug; 62(6):23D-28D. PubMed ID: 3136631 [TBL] [Abstract][Full Text] [Related]
13. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia]. Song Y Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):361-3, 397. PubMed ID: 1821351 [TBL] [Abstract][Full Text] [Related]
14. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion]. Delise P; D'Este D; Bonso A; Allibardi P; Raviele A; Di Pede F; Piccolo E G Ital Cardiol; 1989 Dec; 19(12):1094-104. PubMed ID: 2576799 [TBL] [Abstract][Full Text] [Related]
15. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395 [TBL] [Abstract][Full Text] [Related]
16. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm. Crozier IG; Ikram H; Kenealy M; Levy L Am J Cardiol; 1987 Mar; 59(6):607-9. PubMed ID: 3103410 [TBL] [Abstract][Full Text] [Related]
17. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Hohnloser SH; Zabel M Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287 [TBL] [Abstract][Full Text] [Related]
18. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias. Sellers TD; Kirchhoffer JB; Modesto TA Prog Clin Biol Res; 1987; 230():283-99. PubMed ID: 3295883 [TBL] [Abstract][Full Text] [Related]
19. [The pharmacological treatment of supraventricular atrioventricular nodal reentry or accessory pathway reentry tachycardias: the usefulness of transesophageal electrophysiological study in the selection of therapy]. Sarubbi B; Ducceschi V; Esposito R; Briglia N; Manzo G; Mayer MS; Santangelo L; Iacono A Cardiologia; 1996 Jun; 41(6):543-9. PubMed ID: 8766417 [TBL] [Abstract][Full Text] [Related]
20. Treatment of refractory supraventricular arrhythmias with flecainide acetate. Till JA; Rowland E; Shinebourne EA; Ward DE Arch Dis Child; 1987 Mar; 62(3):247-52. PubMed ID: 3105471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]